{"kind":"fund","name":"4BIO Capital","slug":"4bio-capital","answer":"Yes. According to SeedForge's Active Investor Index, 4BIO Capital's most recent publicly evidenced investment was announced on September 29, 2026 (Aptadir Therapeutics), which is within the last 6 months. The index is refreshed weekly and investors without evidence in the last 180 days are removed.","status":"published","citation":"SeedForge Active Investor Index: 4BIO Capital, latest evidenced participation announced 2026-09-29. Updated 2026-10-12. seedforge.com/investors/funds/4bio-capital--sxfd1e","logo_url":"https://www.google.com/s2/favicons?domain=4biocapital.com&sz=256","page_key":"fund--sxfd1e","publicId":"sxfd1e","seo_title":"4BIO Capital: publicly evidenced deal, 29 Sep 2026 (dated)","round_band":null,"type_label":"VC fund","updated_at":"2026-10-12","ages_out_on":"2027-03-28","check_range":null,"stages_seen":null,"website_url":null,"related_list":null,"coverage_note":"Deals we found in public sources since SeedForge started tracking in August 2026. The fund's full portfolio may be larger.","method_version":"v1.13","participations":[{"round":null,"company":"Aptadir Therapeutics","dated_on":"2026-09-29","announced_on":"2026-09-29","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/annalisa-d-a495724a_aptadir-raises-a-40m-45m-seed-financing-activity-7510711461552394241-PbWP","evidence_path":"/investors/funds/4bio-capital--sxfd1e/evidence/2026-09-29--aptadir-therapeutics","closing_source":null}],"tracking_since":"2026-08","answer_question":"Has 4BIO Capital invested in the last 6 months?","geography_label":"Europe","latest_announced":"2026-09-29","meta_description":"4BIO Capital's most recent publicly evidenced investment: Aptadir Therapeutics, announced September 29, 2026. Refreshed weekly by SeedForge. Free to cite.","corroborated_identity":true,"mandate_geography_label":"APAC · Europe · N. America"}